Tacrolimus Ointment
Product Images NDC 45802-700

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Tacrolimus (NDC 45802-700). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Padagis Israel Pharmaceuticals Ltd, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Tacrolimus 01)

Chemical structure of Tacrolimus, the active ingredient in Tacrolimus topical ointment, showing its molecular formula and arrangement including multiple rings, hydroxyl groups, and methyl groups, along with a hydrate (water) molecule.*

FDA Label Image

Figure 1 (Tacrolimus 02)

A line graph showing the percentage of body surface area affected over 12 weeks for three groups: Vehicle, Tacrolimus 0.03%, and Tacrolimus 0.1%. The y-axis represents the percentage of body surface area affected, and the x-axis represents time in weeks. The graph shows a decrease in affected area over time, with the 0.1% Tacrolimus group showing the greatest reduction.*

FDA Label Image

Figure 2 (Tacrolimus 03)

A line graph depicting the percentage of body surface area affected over 12 weeks. The x-axis represents time in weeks, and the y-axis shows the percentage of body surface area affected with mean plus 95% confidence intervals. Two lines compare a vehicle control and a 0.03% treatment, with the 0.03% line showing a greater decrease in affected area over time.*

FDA Label Image

Figure 3 (Tacrolimus 04)

A line graph depicting mean erythema score over 12 weeks, comparing three treatments: Vehicle, 0.03%, and 0.1%. The y-axis shows mean erythema score with 95% confidence intervals, while the x-axis represents time in weeks. Scores for 0.03% and 0.1% treatments decrease over time, whereas Vehicle remains mostly constant.*

FDA Label Image

Figure 4 (Tacrolimus 05)

A line graph showing mean erythema scores over 12 weeks comparing two treatments: Vehicle and 0.03% Tacrolimus ointment. The y-axis represents mean erythema score with 95% confidence intervals, and the x-axis shows time in weeks. The 0.03% Tacrolimus line decreases over time, while the Vehicle line remains mostly stable.*

FDA Label Image

Principle Display Panel (30 g Tube Carton)

Packaging label for Tacrolimus Ointment 0.03%, topical ointment in a 30 g size. The label displays the brand name Tacrolimus, strength 0.03%, and indicates it is for prescription use only (Rx Only). It is labeled with Padagis as the distributor and includes storage and usage information. The NDC code visible is 45802-390-00.*

FDA Label Image

Principle Display Panel (30 g Tube Carton)

Packaging label for Tacrolimus Ointment 0.1%, topical ointment, 30 g tube, distributed by Padagis Israel Pharmaceuticals Ltd. The label includes usage warnings, storage instructions, and manufacturer information (LEO Laboratories Ltd, Ireland). The design features the Padagis logo and highlights that the product is Rx only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.